Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) has earned an average rating of “Hold” from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price […]
Maravai LifeSciences (NASDAQ:MRVI – Free Report) had its price target decreased by Credit Suisse Group from $14.00 to $11.00 in a report published on Tuesday morning, Benzinga reports. Credit Suisse Group currently has a neutral rating on the stock. Several other equities analysts have also recently issued reports on the stock. The Goldman Sachs Group […]
Maravai LifeSciences (NASDAQ:MRVI – Free Report) had its price objective cut by The Goldman Sachs Group from $12.00 to $8.00 in a research note issued to investors on Tuesday, Benzinga reports. They currently have a neutral rating on the stock. MRVI has been the subject of several other reports. Credit Suisse Group decreased their price […]
Maravai LifeSciences (NASDAQ:MRVI – Get Free Report) had its target price decreased by investment analysts at Credit Suisse Group from $14.00 to $11.00 in a research note issued on Tuesday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Credit Suisse Group’s target price would suggest a potential upside of 14.58% from […]
Maravai LifeSciences (NASDAQ:MRVI – Get Free Report) had its target price dropped by analysts at Bank of America from $15.00 to $12.00 in a report released on Tuesday, FlyOnTheWall reports. Bank of America‘s price target would suggest a potential upside of 6.29% from the company’s current price. Other equities research analysts have also recently issued […]